Jill Brooks

Colleges, School and Institutes

View graph of relations

Most downloaded publications

CD4+ T-cell responses to Epstein-Barr virus (EBV) latent-cycle antigens and the recognition of EBV-transformed lymphoblastoid cell lines
Heather Long, , Nancy Gudgeon, , , Jill Brooks, , , Steve Lee, Alan Rickinson & Graham Taylor, 15 Apr 2005, In: Journal of virology. 79, p. 4896-4907 12 p.

Research output: Contribution to journal › Article › peer-review

231 downloads
Radiotherapy plus cisplatin or cetuximab in low-risk human papillomavirus-positive oropharyngeal cancer (De-ESCALaTE HPV): an open-label randomised controlled phase 3 trial
Hisham Mehanna, Anthony Kong & 18 others, , , , , , , , , , , , , , Paul Nankivell, Jennifer Bryant, Neil Sharma, Rachel Spruce & Jill Brooks, 5 Jan 2019, In: The Lancet. 393, 10166, p. 51-60 10 p.

Research output: Contribution to journal › Article › peer-review

144 downloads
Early T Cell Recognition of B Cells following Epstein-Barr Virus Infection: Identifying Potential Targets for Prophylactic Vaccination
Jill Brooks, Heather Long, Rosemary Tierney, Claire Shannon-Lowe, , , Graham Taylor & Alan Rickinson, 20 Apr 2016, In: PLoS pathogens. 12, 4, p. 1 25 p., e1005549.

Research output: Contribution to journal › Article › peer-review

87 downloads
Development and validation of a combined hypoxia and immune prognostic classifier for head and neck cancer
Jill Brooks, Albert Menezes Antao Nobre De Menezes, Lucinda Archer, Neeraj Lal, Rachel Spruce, Nikos Batis, Jennifer Bryant, Gordon Ryan, Steve Lee, Gary Middleton, Daniel Tennant & 7 others, Andrew Beggs, Jon Deeks, , Jean-Baptiste Cazier, Benjamin Willcox, & Hisham Mehanna, Sep 2019, In: Clinical Cancer Research. 25, 17, p. 5315-5328 15 p.

Research output: Contribution to journal › Article › peer-review

79 downloads
Repurposed quinacrine synergizes with cisplatin, reducing the effective dose required for treatment of head and neck squamous cell carcinoma
Jennifer Bryant, Nikos Batis, , , , Gordon Ryan, Jill Brooks, Andrew Southam, Nicholas Barnes, Jo Parish, Sally Roberts, Farhat Khanim, Rachel Spruce & Hisham Mehanna, 27 Aug 2019, In: OncoTarget. 10, 50, p. 5229-5244 16 p.

Research output: Contribution to journal › Article › peer-review

76 downloads

Recent publications

Lack of predictive tools for conventional and targeted cancer therapy: barriers to biomarker development and clinical translation
Nikos Batis, Jill Brooks, Karl Payne, Neil Sharma, Paul Nankivell & Hisham Mehanna, 27 Jun 2021, (E-pub ahead of print) In: Advanced Drug Delivery Reviews. 113854.

Research output: Contribution to journal › Article › peer-review

Ultra-low DNA Input into whole genome methylation assays and detection of oncogenic methylation and copy number variants in circulating tumour DNA
Celina Whalley, , , , , Jill Brooks, Nikos Batis, Rachel Spruce, , Hisham Mehanna, Paul Nankivell & Andrew Beggs, 19 Feb 2021, In: Epigenomes. 5, 1, 6.

Research output: Contribution to journal › Article › peer-review

Circulating tumour cell expression of immune-markers as prognostic and therapeutic biomarkers in head and neck squamous cell carcinoma: a systematic review and meta-analysis
Matthew Pugh, Jill Brooks, Nikos Batis, Graham Taylor, Paul Nankivell & Hisham Mehanna, 3 Nov 2020, In: International Journal of Molecular Sciences. 21, 21, p. 1-14 14 p., 8229.

Research output: Contribution to journal › Article › peer-review

View all (16)